Moreover, shRNA knockdown of CBAP in CCRF-CEM T-ALL cells also consistently produced cells that exhibited longer disease latency in this leukemic mouse model compared to the control (Fig. 2d and Supplementary Fig. S3d), suggesting that CBAP expression increases the oncogenic activity of leukemia cells in vivo. Here, TMEM102 is linked to acute lymphoblastic leukemia.